In this study, a comprehensive strategy was utilized to identify a dysregulated metabolic network associated with ESCC progression, involving the metabolite biomarkers hypoxanthine and xanthine, the HPRT1 gene, and the purine salvage pathway. This evidence concerns the gene HPRT1 and esophageal squamous cell carcinoma.